Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuvastatic for Cancer-Related Fatigue in Colon Cancer
NCT07669519Phase 3Recruiting
- Sponsor
- Natureceuticals
- Start
- Aug 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 3 trial of Nuvastatic in cancer-related fatigue (CRF), sponsored by Natureceuticals. Started Aug 2025; status: recruiting.
02
Drugs
Nuvastatic
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT07669519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07669519.